VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹28 Cr | ₹27 Cr | ₹41 Cr | ₹62 Cr | ₹-10.00 Cr |
What is the latest Consolidated Net Profit of VENUS REMEDIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹28 Cr |
Mar2023 | ₹27 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹62 Cr |
Mar2020 | ₹-10.00 Cr |
How is Consolidated Net Profit of VENUS REMEDIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹28 Cr | 7.25 | |
Mar2023 | ₹27 Cr | -34.77 | |
Mar2022 | ₹41 Cr | -34.07 | |
Mar2021 | ₹62 Cr | Positive | |
Mar2020 | ₹-10.00 Cr | - |
Compare Consolidated Net Profit of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹424.0 Cr | 6.5% | 2.1% | -21.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 2.7% | -2.4% | 49.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,923.0 Cr | 2.9% | 6.2% | 64.2% | Stock Analytics | |
CIPLA | ₹121,796.0 Cr | 1% | 6.4% | 28.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,919.0 Cr | 1% | -2.3% | 6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,072.6 Cr | 2.4% | -1.1% | 53.4% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 6.5% |
2.1% |
-21.1% |
SENSEX | 0.2% |
-0.2% |
21.6% |
You may also like the below Video Courses